- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06435806
Medical Illustration Design Characteristic Evaluation
July 30, 2025 updated by: Northeastern University
Advancing Medical Illustration in Patient Education Materials: From Art to Science. Study 1: Medical Illustration Design Characteristic Evaluation
The goal of this study is to understand what people understand from medical illustrations, and what meaning and emotions (such as anxiety) they derive from different design elements.
Study Overview
Detailed Description
The investigators will conduct cognitive interviews to understand the meaning laypersons obtain from different illustrations, their opinions on illustration styles, and their level of anxiety after viewing illustrations.
The investigators will also study the effect of systematically varying medical illustration designs on layperson understanding and anxiety.
Study Type
Interventional
Enrollment (Estimated)
8200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Timothy Bickmore, PhD
- Phone Number: 6173735477
- Email: t.bickmore@northeastern.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Not yet recruiting
- Tufts Medical Center
-
Contact:
- Cameron Neeson
- Phone Number: 6176365747
- Email: cameron.neeson@tuftsmedicalcenter.org
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Northeastern University
-
Contact:
- Madison Blain
- Phone Number: (617) - 858 - 6727
- Email: m.blain@northeastern.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Over 18 years old
- Speaks English or Spanish fluently
- Is able to independently consent
- Has adequate corrected vision to read patient education documents
Exclusion Criteria:
* None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Medical Illustration Design Distinction 1, version A
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 1, version B
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 2, version A
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 2, version B
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 3, version A
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 3, version B
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 4, version A
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 4, version B
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 5, version A
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 5, version B
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 6, version A
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 6, version B
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 7, version A
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 7, version B
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 8, version A
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 8, version B
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 9, version A
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 9, version B
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 10, version A
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
|
Experimental: Medical Illustration Design Distinction 10, version B
|
We will test 10 binary design variants for medical illustrations (for example, with and without cut-away, with and without text labels, etc).
Specific variants to be identified during first task of project.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge
Time Frame: Baseline and 30 minutes
|
A multiple-item knowledge test designed to test comprehension of the patient education document
|
Baseline and 30 minutes
|
|
State Anxiety scale from State-Trait Anxiety Inventory
Time Frame: 30 minutes
|
Self-report state anxiety scale from the State-Trait Anxiety Inventory.
20 items, 4-point Likert scale.
A higher score indicates more severe anxiety with a potential range from 20 to 80.
|
30 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reading Effort
Time Frame: 30 minutes
|
Likert items to assess perceived effort in reading a document and illustration
|
30 minutes
|
|
Acceptability
Time Frame: 30 minutes
|
Likert items to assess acceptability and appropriateness of the illustration
|
30 minutes
|
|
Satisfaction with the medical illustration
Time Frame: 30 minutes
|
Likert items to assess satisfaction with the document and illustration
|
30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Timothy Bickmore, PhD, Northeastern University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 25, 2024
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
January 1, 2027
Study Registration Dates
First Submitted
May 21, 2024
First Submitted That Met QC Criteria
May 24, 2024
First Posted (Actual)
May 30, 2024
Study Record Updates
Last Update Posted (Actual)
August 3, 2025
Last Update Submitted That Met QC Criteria
July 30, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 427440
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Transcripts from 100 cognitive interviews, and quantitative measures of comprehension and anxiety from 7,600 participant reactions to patient education documents will be generated.
We will create de-identified data sets of all quantitative human subjects data that will be preserved and shared.
The purpose for creating this is to allow other investigators access to the data to both validate our findings and to further advance inquiry in the field.
IPD Sharing Time Frame
Prior to end of the study.
IPD Sharing Access Criteria
Sharing of de-identified human subjects data will be consistent with HIPAA guidelines and the Final NIH Statement on Sharing Research Data.
We do not anticipate any limitations on sharing.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
Atisama TherapeuticsRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on Medical Illustration design
-
MemorialCare Health SystemActive, not recruitingPreeclampsia | Preeclampsia Postpartum | Preeclampsia Severe | Preeclampsia MildUnited States
-
Semmelweis UniversityNot yet recruitingLactation | Breastfeeding | Breastfeeding Mothers | Breastfeeding Education | Lactating Mother
-
University Hospital, GrenobleGIPSA-LAB; Laboratoire de Psychologie et NeuroCognitionRecruitingStroke | Aphasia Non FluentFrance
-
Biomet Orthopedics, LLCNew Lexington ClinicTerminatedOsteoarthritis | Rheumatoid Arthritis | Knee Arthritis | Degenerative ArthritisUnited States
-
Elizabeth K RhodusNational Institute on Aging (NIA)CompletedAlzheimer DiseaseUnited States
-
Academy of Nutrition and DieteticsHartford Hospital; University of New Mexico; Meals on Wheels Central TexasNot yet recruiting
-
University of Santiago de CompostelaMozo Grau Ticare ImplantsRecruitingPeri-implant Marginal Bone Loss | Peri-implant Bone Level | Transmucosal Abutment Design | Peri-implant Bone LossSpain
-
Shenandoah UniversityCompletedVirtual RealityUnited States
-
October University for Modern Sciences and ArtsRecruitingAccuracy of Artificial Intelligence in Fixed Dental Prosthesis DesignEgypt
-
Bleep, LLCNational Heart, Lung, and Blood Institute (NHLBI)CompletedObstructive Sleep ApneaUnited States